INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

13 Jan 2025 09:45:33 By NetDania Notify

Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.

13 Jan 2025 06:32:27 By Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

10 Jan 2025 09:47:51 By NetDania Notify

Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz 

10 Jan 2025 06:30:00 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 Jan 2025 08:00:11 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Presents Data from the CAPLYTA Adjunctive MDD Phase 3 Program at the American College of Neuropsychopharmacology Annual Meeting

11 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy

03 Dec 2024 07:30:38 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

19 Nov 2024 08:00:53 By Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

11 Nov 2024 09:45:08 By NetDania Notify

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

07 Nov 2024 09:48:04 By NetDania Notify

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress

07 Nov 2024 08:00:18 By Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

06 Nov 2024 09:45:14 By NetDania Notify

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

05 Nov 2024 15:06:30 By NetDania Notify

Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia

05 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

30 Oct 2024 09:50:43 By NetDania Notify

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

30 Oct 2024 07:30:35 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

17 Oct 2024 08:00:33 By Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

23 Sep 2024 08:00:34 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

28 Aug 2024 08:00:04 By Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

08 Aug 2024 08:00:26 By Nasdaq GlobeNewswire